Cargando…
Mouse models of breast cancer in preclinical research
Breast cancer remains the second leading cause of cancer death among woman, worldwide, despite advances in identifying novel targeted therapies and the development of treating strategies. Classification of clinical subtypes (ER+, PR+, HER2+, and TNBC (Triple-negative)) increases the complexity of br...
Autores principales: | Park, Mi Kyung, Lee, Chang Hoon, Lee, Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for Laboratory Animal Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333613/ https://www.ncbi.nlm.nih.gov/pubmed/30671101 http://dx.doi.org/10.5625/lar.2018.34.4.160 |
Ejemplares similares
-
Genetically Engineered Mouse Models for Drug Development and Preclinical Trials
por: Lee, Ho
Publicado: (2014) -
Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models
por: Fiordelisi, M. F., et al.
Publicado: (2019) -
In vivo molecular imaging in preclinical research
por: Kim, Su Jin, et al.
Publicado: (2022) -
Dirofilariasis mouse models for heartworm preclinical research
por: Marriott, A. E., et al.
Publicado: (2023) -
Post-Translational Modification of ZEB Family Members in Cancer Progression
por: Park, Mi Kyung, et al.
Publicado: (2022)